Medical Styrenic Block Copolymer Market Report 2025

This Medical Styrenic Block Copolymer market report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.

The medical styrenic block copolymer market size has grown strongly in recent years. It will grow from $8.27 billion in 2024 to $8.92 billion in 2025 at a compound annual growth rate (CAGR) of 7.8%. The growth in the historic period can be attributed to regulatory compliance, infection control, telemedicine services, precision medicine, global healthcare initiatives.

The medical styrenic block copolymer market size is expected to see strong growth in the next few years. It will grow to $12.54 billion in 2029 at a compound annual growth rate (CAGR) of 8.9%. The growth in the forecast period can be attributed to sterilization resistance, drug delivery systems, flexible medical packaging, medical device manufacturing, tissue engineering, biocompatibility techniques. Major trends in the forecast period include advanced medical devices, biodegradable copolymers, 3D printing, surgical robotics, radiopacity.

The rising healthcare expenditure is expected to drive the growth of the medical styrenic block copolymer market in the future. Healthcare expenditure encompasses average spending on healthcare within an economy, including costs associated with hospitals, home health agencies, and personal healthcare. Medical styrene block copolymer materials are utilized in manufacturing medical products, contributing to their flexibility, stretchability, and elasticity. For example, in March 2022, the 2021-2030 National Health Expenditure (NHE) report published by the Centers for Medicare & Medicaid Services, a US-based federal agency, projected that national health spending would grow by an average of 5.1% annually from 2021 to 2030, ultimately reaching nearly $6.8 trillion. Furthermore, it is expected that Medicare spending will increase at an annual rate of 7.2%, while Medicaid spending will rise at 5.6% per year during the same period. Thus, the increasing healthcare expenditure is driving the growth of the medical styrene block copolymer market.

The growth of the medical styrenic block copolymer market is further propelled by the demand from the medical device industry. This industry encompasses a diverse range of instruments and equipment crucial for healthcare purposes. Medical styrenic block copolymers find extensive use in medical devices due to their biocompatibility, flexibility, and resistance to sterilization methods. Applications include catheters, IV tubing, and surgical instruments. For example, according to MedTech Europe, around 11% of GDP in Europe is allocated to healthcare, with approximately 7.6% attributed to medical technologies. The expenditure on medical technology varies across European countries, ranging from 5% to 12% of total healthcare spending. The per capita expenditure on medical technology in Europe averages around $346.08 (€284). The demand from the medical device industry is thus a significant driver for the medical styrenic block copolymer market.

Major companies in the medical styrenic block copolymer market are concentrating on expanding production to enhance their competitive position. Increasing the production of medical styrenic block copolymers is crucial to meet the rising healthcare demands and ensure a steady supply of high-quality materials used in medical devices and packaging. For instance, in June 2022, Kraton Corporation, a US-based manufacturer of specialty polymers and biobased chemicals, announced the expansion of its manufacturing facilities in Berre, France. This expansion will produce up to 100% ISCC PLUS certified Renewable Styrenic Block Copolymers (SBC) as part of the CirKular+ ReNew Series, utilizing a mass balance approach. The CirKular+ ReNew Series is designed to reduce the cradle-to-gate carbon footprint (including biogenic carbon) by up to 85% compared to fossil-based products produced in Berre. This significant advancement highlights Kraton's commitment to the circular economy and offers customers sustainable and innovative solutions.

Strategic partnerships are a focal point for major companies in the medical styrenic block copolymer market, aiming to drive revenue growth. Collaborative efforts through partnerships enhance research and development capabilities, broaden market reach, and foster innovation. In January 2022, Agilyx partnered with Toyo Styrene to develop a chemical recycling facility in Japan, focusing on recycling post-use polystyrene plastic into styrene monomer. This collaborative venture utilizes Agilyx's advanced chemical recycling process and signifies a significant step in addressing sustainability concerns.

In March 2022, Kraton, a US-based manufacturer of specialty polymers, merged with DL Chemical Co. Ltd. This merger enables Kraton to strengthen its global presence by leveraging DL Chemical's manufacturing capabilities and footprint in the Asian market, as well as its financial strength, which allows Kraton to further invest in advanced sustainable innovations. Additionally, this merger drives both DL Chemical and Kraton toward their common goal of becoming global leaders in specialty chemicals. DL Chemical Co. Ltd. is a Korea-based producer of medical styrenic block copolymers.

Major companies operating in the medical styrenic block copolymer market include Zeon Corporation, TSRC Corporation, Kumho Petrochemical Co. Ltd., LCY Chemical Corp., INEOS Styrolution Group GmbH, Trinseo S.A., RTP Company, LG Chem Ltd., China Petroleum & Chemical Corporation (Sinopec Corp.), Dynasol Group, Asahi Kasei Corporation, BASF SE, Versalis S.p.A., DENKA Company Limited, En Chuan Chemical Industries Co. Ltd., JSR Corporation, Eastman Chemical Company, Chi Mei Corporation, Kraton Corporation, Chevron Phillips Chemical Company LLC, Styrolution Group GmbH, Kuraray Co. Ltd., Korea Kumho Petrochemical Co. Ltd.

North America was the largest region in the medical styrenic block copolymer market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the medical styrenic block copolymer market share report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the medical styrenic block copolymer market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

Medical styrene block copolymers refer to a category of thermoplastic elastomers that exhibit plastic-like appearance but rubber-like behavior. These materials provide flexibility, stretchability, and elasticity to products. They can serve as alternatives to natural rubber, silicone rubber, thermoplastic polyurethane (TPU), or polyvinyl chloride (PVC). The medical styrenic block copolymer market is involved in the manufacturing of various medical products, including surgical drapery, needle shields, dental dams, drip chambers, and exercise bands.

The main types of medical styrene block copolymers include styrene ethylene butadiene styrene (SEBS), styrene isoprene butadiene (SIBS), and styrene-butadiene-styrene (SBS). Styrene isoprene butadiene is a thermoplastic elastomer blend that combines the elasticity and resilience of butadiene rubber or isoprene rubber (natural rubber) with the moldability of polystyrene under the influence of heat. This type is used in the production of diapers, sanitary pads, and other hygienic products. Various applications of medical styrene block copolymers include tubing, medical bags, equipment, packaging, diagnostic products, wound care, and more.

The medical styrenic block copolymer market research report is one of a series of new reports that provides medical styrenic block copolymer market statistics, including medical styrenic block copolymer market industry global market size, regional shares, competitors with a medical styrene block copolymer market share, detailed medical styrene block copolymer market segments, market trends and opportunities, and any further data you may need to thrive in the medical styrenic block copolymer market industry. This medical styrene block copolymer market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The medical styrenic block copolymer market consists of sales of polystyrene (PS), acrylonitrile butadiene styrene (ABS), styrene butadiene rubber (SBR), expandable polystyrene (EPS), and unsaturated polyester resins (UPR). Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.